Author Topic: Tyrosine kinase inhibitors related to pois  (Read 2328 times)


  • Hero Member
  • *****
  • Posts: 942
Tyrosine kinase inhibitors related to pois
« on: January 24, 2022, 04:18:48 PM »

As i think that somethig toxic-eg infection disbturb ours
signaling pathways in the body:

Reve case:

Protein kinases, as key regulators of most cellular pathways, are frequently associated with diseases, either as triggers or as therapeutic intervention points.

The protein kinase family offers a challenge but also an enormous opportunity for drug discovery. Disease arises when signal transduction in a cell breaks down, thereby removing the tight control that typically exists over cellular functions. Devastating diseases, such as cancer, neurological disorders, inflammation, autoimmune diseases, psoriasis, allergic reactions, and hormone-related diseases, can result from abnormal signal transduction.
« Last Edit: January 24, 2022, 04:27:22 PM by Hopeoneday »


  • Hero Member
  • *****
  • Posts: 3023
    • MCAD Thread
Re: Tyrosine kinase inhibitors related to pois
« Reply #2 on: April 19, 2022, 11:32:19 AM »


2nd link about PKC shows a couple of 5HT receptors that have been discussed playing a role in premature ejaculation, 2A and 2C.
Also: "endothelial injury and tissue damage related to cigarette smoke". Nas gets POIS symptoms from cigarette smoke.

Hmm it seems it can activate the PI3K/AKT pathway if I'm not mistaken, that one is actually leading to mTOR which is a mast cell activator as well. "Low-level PKC activation is sufficient to reverse cell chirality through phosphatidylinositol 3-kinase/AKT signaling and alters junctional protein organization between cells with opposite chirality, leading to an unexpected substantial change in endothelial permeability, which often leads to inflammation and disease."
« Last Edit: April 19, 2022, 12:16:34 PM by Muon »